Marcel R.M. van den Brink

ORCID: 0000-0003-0696-4401
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Gut microbiota and health
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Clostridium difficile and Clostridium perfringens research
  • Neutropenia and Cancer Infections
  • Acute Myeloid Leukemia Research
  • Cytomegalovirus and herpesvirus research
  • Acute Lymphoblastic Leukemia research
  • Microscopic Colitis
  • Mycobacterium research and diagnosis
  • Cancer Immunotherapy and Biomarkers
  • Genomics, phytochemicals, and oxidative stress
  • Renal Transplantation Outcomes and Treatments
  • Oral health in cancer treatment
  • Polyomavirus and related diseases
  • Lymphoma Diagnosis and Treatment
  • IL-33, ST2, and ILC Pathways
  • Chronic Lymphocytic Leukemia Research
  • Clinical Nutrition and Gastroenterology
  • Immunodeficiency and Autoimmune Disorders
  • Virus-based gene therapy research
  • Mesenchymal stem cell research

Memorial Sloan Kettering Cancer Center
2016-2025

Cornell University
2016-2025

City Of Hope National Medical Center
2024-2025

City of Hope
2024-2025

Helios Dr. Horst Schmidt Kliniken Wiesbaden
2025

Beckman Research Institute
2025

Kettering University
2014-2024

Parker Institute for Cancer Immunotherapy
2023-2024

Weill Cornell Medicine
2022-2024

Princess Máxima Center
2024

Acute myeloid leukemia (AML) is a heterogeneous disease with respect to presentation and clinical outcome. The prognostic value of recently identified somatic mutations has not been systematically evaluated in phase 3 trial treatment for AML.We performed mutational analysis 18 genes 398 patients younger than 60 years age who had AML were randomly assigned receive induction therapy high-dose or standard-dose daunorubicin. We validated our findings an independent set 104 patients.We at least...

10.1056/nejmoa1112304 article EN New England Journal of Medicine 2012-03-14

Bacteremia is a frequent complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT). It unclear whether changes in the intestinal microbiota during allo-HSCT contribute to development bacteremia. We examined patients undergoing allo-HSCT, and correlated microbial shifts with risk bacteremia.Fecal specimens were collected longitudinally from 94 before transplant until 35 days after transplant. The was characterized by 454 pyrosequencing V1-V3 region bacterial 16S ribosomal...

10.1093/cid/cis580 article EN Clinical Infectious Diseases 2012-06-20

Bloodstream infection by highly antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a growing clinical problem that increasingly defies medical intervention. Identifying patients at high risk for bacterial sepsis remains an important challenge. Recent studies have shown antibiotics can alter microbial diversity in the intestine. Here, we characterized these effects using 16s rDNA pyrosequencing and demonstrated antibiotic treatment of mice enabled exogenously...

10.1172/jci43918 article EN Journal of Clinical Investigation 2010-11-22

The relationship between intestinal microbiota composition and acute graft-versus-host disease (GVHD) after allogeneic blood/marrow transplantation (allo-BMT) is not well understood. Intestinal bacteria have long been thought to contribute GVHD pathophysiology, but recent animal studies in nontransplant settings found that anti-inflammatory effects are mediated by certain subpopulations of commensals. Hypothesizing a more nuanced may exist the GVHD, we evaluated fecal bacterial 64 patients...

10.1016/j.bbmt.2015.04.016 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2015-05-11

Despite a growing understanding of the link between intestinal inflammation and resident gut microbes, longitudinal studies human flora before initial onset have not been reported. Here, we demonstrate in murine recipients allogeneic bone marrow transplantation (BMT) that secondary to graft-versus-host disease (GVHD) is associated with major shifts composition microbiota. The microbiota, turn, can modulate severity inflammation. In mouse models GVHD, observed loss overall diversity expansion...

10.1084/jem.20112408 article EN cc-by-nc-sa The Journal of Experimental Medicine 2012-04-30

ABSTRACT Bacteria causing infections in hospitalized patients are increasingly antibiotic resistant. Classical infection control practices only partially effective at preventing spread of antibiotic-resistant bacteria within hospitals. Because the density intestinal colonization by highly bacterium vancomycin-resistant Enterococcus (VRE) can exceed 10 9 organisms per gram feces, even optimally implemented hygiene protocols often fail. Decreasing colonization, therefore, represents an...

10.1128/iai.01197-12 article EN Infection and Immunity 2013-01-15

Ionizing radiation causes acute syndrome, which leads to hematopoietic, gastrointestinal, and cerebrovascular injuries. We investigated a population of mice that recovered from high-dose live normal life spans. These "elite-survivors" harbored distinct gut microbiota developed after protected against radiation-induced damage death in both germ-free conventionally housed recipients. Elevated abundances members the bacterial taxa

10.1126/science.aay9097 article EN Science 2020-10-29

Endogenous thymic regeneration is a crucial function that allows for renewal of immune competence after stress, infection, or immunodepletion. However, the mechanisms governing this remain poorly understood. We detail such mechanism, centered on interleukin-22 (IL-22) and triggered by depletion CD4(+)CD8(+) double-positive thymocytes. Intrathymic levels IL-22 were increased insult, recovery was impaired in IL-22-deficient mice. IL-22, which signaled through epithelial cells promoted their...

10.1126/science.1218004 article EN Science 2012-03-03

Purpose The major causes of mortality after allogeneic hematopoietic-cell transplantation (allo-HCT) are relapse, graft-versus-host disease (GVHD), and infection. We have reported previously that alterations in the intestinal flora associated with GVHD, bacteremia, reduced overall survival allo-HCT. Because bacteria potent modulators systemic immune responses, including antitumor effects, we hypothesized components could be relapse Methods microbiota 541 patients admitted for allo-HCT was...

10.1200/jco.2016.70.3348 article EN Journal of Clinical Oncology 2017-03-15
Coming Soon ...